Nuveen Asset Management, LLC Cel Sci Corp Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $302,773 - $585,596	-117,354 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.93 - $7.7 $3,144 - $6,160	800 Added 0.69%	117,354 $510,000
Q4 2021 Feb 14, 2022	SELL	$7.1 - $12.82 $71,376 - $128,879	-10,053 Reduced 7.94%	116,554 $869,000
Q3 2021 Nov 12, 2021	SELL	$7.64 - $12.49 $37,649 - $61,550	-4,928 Reduced 3.75%	126,607 $1.54 Million
Q2 2021 Aug 16, 2021	SELL	$8.68 - $27.49 $18,436 - $58,388	-2,124 Reduced 1.59%	131,535 $1.14 Million
Q1 2021 May 17, 2021	BUY	$12.0 - $27.64 $86,724 - $199,754	7,227 Added 5.72%	133,659 $2.03 Million
Q4 2020 Feb 16, 2021	SELL	$11.05 - $16.62 $122,124 - $183,684	-11,052 Reduced 8.04%	126,432 $1.48 Million
Q3 2020 Nov 16, 2020	BUY	$11.69 - $14.54 $33,690 - $41,904	2,882 Added 2.14%	137,484 $1.75 Million
Q2 2020 Aug 14, 2020	SELL	$9.75 - $17.6 $21,596 - $38,984	-2,215 Reduced 1.62%	134,602 $2.01 Million
Q1 2020 May 14, 2020	SELL	$7.54 - $17.05 $145,054 - $328,007	-19,238 Reduced 12.33%	136,817 $1.58 Million
Q4 2019 Feb 14, 2020	SELL	$6.71 - $9.55 $2,965 - $4,221	-442 Reduced 0.28%	156,055 $1.43 Million
Q3 2019 Nov 14, 2019	BUY	$6.0 - $9.6 $450,906 - $721,449	75,151 Added 92.38%	156,497 $1.4 Million
Q2 2019 Aug 15, 2019	BUY	$3.77 - $8.67 $306,674 - $705,269	81,346 New	81,346 $682,000

5.98M

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $24.3M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.